Study skin and blood signs in ichthyosis
Part of Genetic & congenital, Skin clinical trials.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 1 and 60 years old when you enroll
- If you have ichthyosis, your diagnosis must be Netherton syndrome, lamellar ichthyosis, or another ichthyosis type
- For ichthyosis: avoid anti-inflammatory pills by 1 month before blood/skin sampling
- For ichthyosis: avoid anti-inflammatory creams by 1 week before sampling
- For skin sampling: do not apply lotions (emollients) to the exact biopsy spots within 12 hours before the biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a moisturizer called Doublebase Once in people with ichthyosis (a condition causing dry, scaly skin). For one month, you'd use this product once daily instead of your usual moisturizer to see if it works well and is safe.
This study looks at the bacteria on the skin and in the gut of people with Netherton syndrome, a condition that affects the skin barrier and often causes allergies. It also compares these findings to healthy volunteers to understand how the microbiome might be different.
This study tests whether an antibiotic called gentamicin, given as an injection, can improve symptoms of hereditary ichthyosis, a genetic skin condition that causes severe dryness and scaling. If you have moderate to severe ichthyosis due to certain gene changes, this treatment might help your skin produce the missing proteins.
This study tests an oral medication called erlotinib (an EGFR inhibitor) to see if it can reduce the skin symptoms of keratinopathies like epidermolytic ichthyosis, epidermolytic palmoplantar keratoderma, and pachyonychia congenita. The goal is to improve skin condition and quality of life.
This study looks at blood cells in people with a rare form of ichthyosis caused by NIPAL4 gene mutations. It aims to understand how the immune system might be affected, which could help improve future care.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.